Showing 361-370 of 3417 results for "".
FDA Approves New Melanoma Treatment with Novel MOA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dwtv-9-11-14--iloojede/19075/Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalled.Understanding Male Aesthetics
https://practicaldermatology.com/topics/practice-management/understanding-male-aesthetics/19118/As the male aesthetic market continues to grow, dermatologists need to understand aesthetic differences between men and women and recognize how these will influence treatment decisions. Terrence Keaney, MD talks about Botox and neurotoxins, dermal fillers, and lasers used to treat men.Attendees describe Cosmetic Surgery Forum
https://practicaldermatology.com/topics/practice-management/attendees-describe-cosmetic-surgery-forum/19179/Cosmetic Surgery Forum is a discussion-based symposium for dermatology and skin care professionals from across the country. Watch this video of attendees who describe their experiences and the knowledge they took away from the conference. For more information, visit www.cosmeticsurgeryforum.comPoly-Organic Brightening Peel
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/poly-organic-brightening-peel/19396/Dr. Samuels talks about the benefits of the Poly-Organic Brightening Peel and how he felt the industry needed a peel that brightened, lightened and firmed the skin with minimal downtime. Keyword: Peels0911Spectra Peel for Acne
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/spectra-peel/19522/Demonstration of SpectraPeel for acne and rejuvenation, using pulse and Q-switched modes. Presented by Kevin Deuplechain, MDNew Allergens Causing Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-allergens-causing-contact-dermatitis/54644/Walter J. Liszewski, MD, discusses key takeaways from the “Contact Dermatitis Update 2026” session at Maui Derm Hawaii 2026.The Latest in Blistering Diseases
https://reachmd.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Recap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joFDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.